Danofloxacin
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| Common Name | Danofloxacin(F05771) |
| 2D Structure | |
| FRCD ID | F05771 |
| CAS Number | 112398-08-0 |
| PubChem CID | 71335 |
| Formula | C19H20FN3O3 |
| IUPAC Name | 1-cyclopropyl-6-fluoro-7-[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-4-oxoquinoline-3-carboxylic acid |
| InChI Key | QMLVECGLEOSESV-RYUDHWBXSA-N |
| InChI | InChI=1S/C19H20FN3O3/c1-21-7-12-4-11(21)8-22(12)17-6-16-13(5-15(17)20)18(24)14(19(25)26)9-23(16)10-2-3-10/h5-6,9-12H,2-4,7-8H2,1H3,(H,25,26)/t11-,12-/m0/s1 |
| Canonical SMILES | CN1CC2CC1CN2C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F |
| Isomeric SMILES | CN1C[C@@H]2C[C@H]1CN2C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F |
| Synonyms |
NCGC00164548-01
Danofloxacin
112398-08-0
Danofloxacine
Danofloxacino
Danofloxacinum
UNII-24CU1YS91D
24CU1YS91D
C19H20FN3O3
DSSTox_CID_26432
|
| Classifies |
Predicted: Veterinary Drug
|
| Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
| Kingdom | Organic compounds |
| Superclass | Organoheterocyclic compounds |
| Class | Quinolines and derivatives |
| Subclass | Quinoline carboxylic acids |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Quinoline carboxylic acids |
| Alternative Parents |
|
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Quinoline-3-carboxylic acid - Fluoroquinolone - N-arylpiperazine - Aminoquinoline - Haloquinoline - Dihydroquinolone - Dihydroquinoline - Pyridine carboxylic acid or derivatives - Pyridine carboxylic acid - Tertiary aliphatic/aromatic amine - Dialkylarylamine - N-methylpiperazine - N-alkylpiperazine - Piperazine - Aryl halide - Aryl fluoride - 1,4-diazinane - Pyridine - N-alkylpyrrolidine - Benzenoid - Heteroaromatic compound - Vinylogous amide - Pyrrolidine - Amino acid or derivatives - Tertiary amine - Tertiary aliphatic amine - Amino acid - Azacycle - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Organic nitrogen compound - Hydrocarbon derivative - Amine - Organic oxide - Organohalogen compound - Organofluoride - Organopnictogen compound - Organic oxygen compound - Organonitrogen compound - Organooxygen compound - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 357.385 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Complexity | 679 |
| Monoisotopic Mass | 357.149 |
| Exact Mass | 357.149 |
| XLogP | -0.3 |
| Formal Charge | 0 |
| Heavy Atom Count | 26 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB- | 0.9041 |
| Human Intestinal Absorption | HIA+ | 0.9957 |
| Caco-2 Permeability | Caco2+ | 0.8346 |
| P-glycoprotein Substrate | Substrate | 0.7522 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9017 |
| Non-inhibitor | 0.8313 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6180 |
| Distribution | ||
| Subcellular localization | Lysosome | 0.5035 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.7999 |
| CYP450 2D6 Substrate | Non-substrate | 0.8480 |
| CYP450 3A4 Substrate | Non-substrate | 0.5895 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8330 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8611 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8814 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7717 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8609 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7240 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8819 |
| Non-inhibitor | 0.8685 | |
| AMES Toxicity | AMES toxic | 0.7906 |
| Carcinogens | Non-carcinogens | 0.8923 |
| Fish Toxicity | High FHMT | 0.9991 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9293 |
| Honey Bee Toxicity | Low HBT | 0.8852 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.7524 |
| Carcinogenicity (Three-class) | Non-required | 0.5795 |
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -3.3284 | LogS |
| Caco-2 Permeability | 1.5047 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 2.2811 | LD50, mol/kg |
| Fish Toxicity | 1.0194 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.6698 | pIGC50, ug/L |
MRLs
| Food | Product Code | Country | MRLs | Application Date | Notes |
|---|---|---|---|---|---|
| Muscle Of Cattle | United States | 0.2ppm | |||
| Liver Of Cattle | United States | 0.2ppm | |||
| Other Aquatic Animal | Japan | 0.1ppm | |||
| Crustaceans | Japan | 0.1ppm | |||
| Shelled Molluscas | Japan | 0.1ppm | |||
| Other Fish | Japan | 0.1ppm | |||
| Perciformes | Japan | 0.1ppm | |||
| Anguilliformes | Japan | 0.1ppm | |||
| Salmoniformes | Japan | 0.1ppm | |||
| Other Poultry Animals,Edible Offal | Japan | 0.4ppm | |||
| Chicken,Edible Offal | Japan | 0.4ppm | |||
| Other Poultry Animals,Kidney | Japan | 0.4ppm | |||
| Other Poultry Animals,Liver | Japan | 0.4ppm | |||
| Other Poultry Animals,Fat | Japan | 0.1ppm | |||
| Other Poultry Animals,Muscle | Japan | 0.2ppm | |||
| Milk | Japan | 0.05ppm | |||
| Other Terrestrial Mammals,Edible Offal | Japan | 0.4ppm | |||
| Pig,Edible Offal | Japan | 0.05ppm | |||
| Cattle,Edible Offal | Japan | 0.4ppm | |||
| Other Terrestrial Mammals,Kidney | Japan | 0.4ppm |
References
| Title | Journal | Date | Pubmed ID |
|---|---|---|---|
| Hexafluoroisopropanol-induced salt-free catanionic surfactant coacervateextraction method for determination of fluoroquinolones in milk samples. | Food Chem | 2018 Mar 1 | 29037667 |
| Flaxseed-enriched diets change milk concentration of the antimicrobialdanofloxacin in sheep. | BMC Vet Res | 2018 Jan 15 | 29334949 |
| Pharmacokinetics and distribution in interstitial and pulmonary epithelial liningfluid of danofloxacin in ruminant and preruminant calves. | J Vet Pharmacol Ther | 2017 Apr | 27476495 |
| Effect of various storage conditions on the stability of quinolones in raw milk. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2016Jul | 27258809 |
| Microbial screening for quinolones residues in cow milk by bio-optical method. | J Pharm Biomed Anal | 2015 Mar 15 | 25555518 |
| Luminescent determination of quinolones in milk samples by liquidchromatography/post-column derivatization with terbium oxide nanoparticles. | J Chromatogr A | 2015 Jul 31 | 26077970 |
| Short communication: The gain-of-function Y581S polymorphism of the ABCG2transporter increases secretion into milk of danofloxacin at the therapeutic dosefor mastitis treatment. | J Dairy Sci | 2015 Jan | 25465626 |
| Fabrication of enrofloxacin imprinted organic-inorganic hybrid mesoporous sorbentfrom nanomagnetic polyhedral oligomeric silsesquioxanes for the selectiveextraction of fluoroquinolones in milk samples. | J Chromatogr A | 2014 Sep 26 | 25171943 |
| In vitro selection of RNA aptamers that selectively bind danofloxacin. | Biochem Biophys Res Commun | 2014 Jun 13 | 24792181 |
| Development of a novel genetically modified bioluminescent-bacteria-based assayfor detection of fluoroquinolones in animal-derived foods. | Anal Bioanal Chem | 2014 Dec | 25354889 |
| Novel in vitro systems for prediction of veterinary drug residues in ovine milkand dairy products. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2014 | 24679113 |
| Chemiluminescence competitive indirect enzyme immunoassay for 20 fluoroquinolone residues in fish and shrimp based on a single-chain variable fragment. | Anal Bioanal Chem | 2013 Sep | 23842902 |
| Effects of triclabendazole on secretion of danofloxacin and moxidectin into themilk of sheep: role of triclabendazole metabolites as inhibitors of the ruminant ABCG2 transporter. | Vet J | 2013 Nov | 23981352 |
| Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein:effect on plasma and milk levels of danofloxacin in sheep. | Vet J | 2013 May | 23083838 |
| Direct determination of danofloxacin and flumequine in milk by use offluorescence spectrometry in combination with partial least-squares calibration. | J Agric Food Chem | 2013 Mar 20 | 23432704 |
| The bovine ATP-binding cassette transporter ABCG2 Tyr581Ser single-nucleotidepolymorphism increases milk secretion of the fluoroquinolone danofloxacin. | Drug Metab Dispos | 2013 Mar | 23230133 |
| Terbium-sensitised luminescence screening method for fluoroquinolones in beefserum. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2013 | 23472630 |
| Production of the broad specific monoclonal antibody against sarafloxacin forrapid immunoscreening of 12 fluoroquinolones in meat. | J Environ Sci Health B | 2013 | 23305282 |
| Highly sensitive synchronous fluorescence measurement of danofloxacin inpharmaceutical and milk samples using aluminium (III) enhanced fluorescence. | J Fluoresc | 2012 Sep | 22730138 |
| Analysis of quinolone antibiotics in eggs: preparation and characterization of a raw material for method validation and quality control. | Food Chem | 2012 Oct 1 | 25005999 |